Pontano Laura L, Diehl J Alan
The Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Cell Cycle. 2009 Mar 15;8(6):824-7. doi: 10.4161/cc.8.6.7889. Epub 2009 Mar 20.
Ubiquitin mediated degradation of cyclin D1 following the G(1)/S transition counters its mitogen-dependent accumulation during G(1) phase of the cell cycle. Although the cellular machinery responsible for this process has been identified, how this regulatory pathway interfaces with cellular stress responses, often referred to as checkpoints, remains to be established. One intensely investigated checkpoint is the cellular response to DNA damage. When DNA damage is sensed, the corresponding DNA damage checkpoint triggers the inhibition of CDK-dependent cell cycle progression, with arrest coordinated by induction of CDK inhibitors and rapid degradation of specific cyclins, such as cyclin D1. In recent work, we identified a phosphorylation- and Fbx4-dependent cyclin D1 degradation mechanism in response to genotoxic stress.(18) This work revealed that loss of cyclin D1 regulation compromises the intra-S-phase response to DNA damage, promoting genomic instability and sensitization of cells to S-phase chemotherapy, highlighting a potential therapeutic strategy for cancers exhibiting cyclin D1 accumulation.
在细胞周期的G1期,泛素介导的细胞周期蛋白D1在G1/S转换后降解,抵消了其在有丝分裂原依赖下的积累。尽管负责这一过程的细胞机制已被确定,但这条调控途径如何与通常被称为检查点的细胞应激反应相互作用仍有待确定。一个被深入研究的检查点是细胞对DNA损伤的反应。当检测到DNA损伤时,相应的DNA损伤检查点会触发对CDK依赖的细胞周期进程的抑制,通过诱导CDK抑制剂和特定细胞周期蛋白(如细胞周期蛋白D1)的快速降解来协调细胞周期停滞。在最近的研究中,我们发现了一种响应基因毒性应激的磷酸化和Fbx4依赖的细胞周期蛋白D1降解机制。这项研究表明,细胞周期蛋白D1调控的缺失会损害细胞在S期对DNA损伤的反应,促进基因组不稳定并使细胞对S期化疗敏感,这突出了一种针对表现出细胞周期蛋白D1积累的癌症的潜在治疗策略。